Long-term results of a phase II study of rituximab and bendamustine for mucosa-associated lymphoid tissue lymphoma

Salar A (1), Domingo-Domenech E (2), Panizo C (3), Nicolás C (4), Bargay J (5), Muntañola A (6), Canales M (7), Bello JL (8), Sancho JM (9), Tomás JF (10), Rodríguez MJ (11), Peñalver J (12), Grande C (13), Sánchez-Blanco JJ (14), Palomera L (15), Arranz R (16), Conde E (17), García M (18), García JF (19), Caballero D (20), Montalbán C (10).